annual report - IMDEA
During 2022 we started to unfold the Research Programmes de- fined in the proposal that led to the second Award as a ?Severo.
Dissecting AXL-mediated resistance to EGFR-targeted therapies in ...Cell 2020;182:1232-51.e22. 184. Davidson S, Efremova M, Riedel A, et al ... Wu TD, Nacu S. Fast and SNP-tolerant detection of complex variants and ... F magnetic resonance spectroscopy of 5-fluorouracil in the treatment ...T. D. Armstrong, N. Zaidi, E. J. Fertig, J. C. Denny, B. H. Park, Z ... Cell 182, 1232-1251.e22 (2020). 986. 57. S. Bruni, M. F. ... Juki LK-232.pdfThe approval of immunotherapy for stage II-IV melanoma has underscored the need for improved immune-based predictive and prognostic ...
Autres Cours:
